NeueHealth (NYSE:NEUE – Get Free Report) is one of 14 publicly-traded companies in the “Hospital & medical service plans” industry, but how does it contrast to its competitors? We will compare NeueHealth to similar businesses based on the strength of its risk, profitability, analyst recommendations, institutional ownership, valuation, dividends and earnings.
Profitability
This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
NeueHealth | -71.23% | N/A | -1.21% |
NeueHealth Competitors | -0.11% | -1.57% | -0.01% |
Valuation & Earnings
This table compares NeueHealth and its competitors gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
NeueHealth | $1.16 billion | -$1.15 billion | -0.04 |
NeueHealth Competitors | $80.60 billion | $2.78 billion | 9.49 |
Volatility and Risk
NeueHealth has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, meaning that their average stock price is 5% less volatile than the S&P 500.
Institutional and Insider Ownership
63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and price targets for NeueHealth and its competitors, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
NeueHealth Competitors | 94 | 1117 | 2564 | 98 | 2.69 |
NeueHealth presently has a consensus price target of $8.00, suggesting a potential upside of 25.67%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.72%. Given NeueHealth’s higher probable upside, research analysts clearly believe NeueHealth is more favorable than its competitors.
Summary
NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.
NeueHealth Company Profile
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.